Cordyceps and immune

What 2 graded rows on cordyceps agree on for immune, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Cordyceps page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Cordyceps page, with its PubMed record.

Supplement

Cordyceps Choose another

2 rows · 119 people

They agree: both rows found an improvement.

No difference

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside.

From the rows

The best-graded row, grade C, is a randomized trial of 79 people (2015) and found an improvement.

The rows run from 40 to 79 people, published from 2015 to 2024: 2 single studies.

2 improved

Grade CNatural killer cell activity and lymphocyte proliferation · Improved
RCT · n 79 · 2015 · Healthy Korean men
1.5 g/day · 4 weeks
NK cell activity, lymphocyte proliferation, IL-2 and interferon-gamma rose more than with placebo; other Th1 cytokines did not. No statistically significant adverse reactions.
Row on the Cordyceps page · PubMed 26284906 (opens PubMed)
Grade DNatural killer cell activity (fermented C. militaris drink) · Improved
RCT · n 40 · 2024 · Healthy Thai men and women aged 25–60
75 mL/day containing at least 2.85 mg cordycepin · 8 weeks
In women, NK cell activity rose significantly more than with placebo by week 8; in men it rose from baseline by week 4. Blood sugar, lipids and liver, kidney and blood safety tests did not differ between groups.
Row on the Cordyceps page · PubMed 38580687 (opens PubMed)